The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?

The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?

<p>Abstract</p> <p>The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) Trial tested the hypothesis that intensive lowering of cholesterol with atorvastatin (80 mg/day) initiated 24-96 h after an acute coronary syndrome would, over 4 months, reduce the inciden...

Full description

Bibliographic Details
Main Authors: Olsson Anders G, Schwartz Gregory G, Waters David
Format: Article
Language:English
Published: BMC 2001-05-01
Series:Current Controlled Trials in Cardiovascular Medicine
Subjects:
atorvastatin
3-hydroxy-3-methylglutaryl CoA reductase inhibitor
myocardial infarction
unstable angina
Online Access:http://cvm.controlled-trials.com/content/2/3/111

Internet

http://cvm.controlled-trials.com/content/2/3/111

Similar Items